Dr. Cheung received her BSc and PhD degrees in Bioengineering from the University of California, Berkeley, in 1998 and 2002, respectively. From 2002–2005, she was a postdoctoral researcher at the Ecole Polytechnique Fédérale de Lausanne, Switzerland. Her research interests include lab-on-a-chip systems for cell culture and characterization, inkjet printing for tissue engineering, and implantable neural interfaces. Current research projects involve miomedical microsystems for diagnostic and therapeutic applications, dielectric spectroscopy for flow cytometry, implantable polymer-based microelectrode arrays, and integrated cell culture systems.
Dr. Madden worked as a research scientist at MIT before joining UBC in 2002. He completed his PhD work in the BioInstrumentation Laboratory at MIT. His bachelor’s degree is in Honours Physics, UBC and he has a master’s degree in Biomedical Engineering, McGill. John Madden and his team are investigating new and unusual electronic materials for application in printable electronics, sensors and as artificial muscle, using materials including conducting polymers, carbon nanotubes and electrospun carbon nanofibers.
Dr. Tetzlaff is the Director of ICORD and a Professor in the Departments of Zoology and Surgery at the University of British Columbia. He also holds the John and Penny Ryan BC Leadership Chair in Spinal Cord Research. He obtained his M.D. at the University of Essen, completed his Dr. Med. at Ruhr-University Bochum and his Ph.D. at the University of Calgary. Dr. Tetzlaff’s ultimate vision is to combine multiple strategies to encourage nerve cells to grow and enhance recovery after spinal cord injury. His lab is working to translate research findings in restorative medicine into clinical practice.
Dr. Fraser received his Masters in Chemistry from the University of Bristol in 2010 and his PhD in Chemistry from the University of Cambridge in 2015. As part of Cambridge’s EPSRC CDT in Nanoscience and Nanotechnology (NanoDTC), his thesis focused on the application of nanostructured catalysts for hydrogen fuel cells and catalytic converters. Dr. Fraser’s industry experience includes strategy consulting and management for multinationals and start-up companies in the telecoms, media and technology (TMT) and health sectors.